Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,122 | 53,001 | 60,385 | 68,204 | 23,631 |
| Receivables | 208 | 32 | 27 | 145 | 449 |
| TOTAL | $47,814 | $54,024 | $62,001 | $70,297 | $27,275 |
| Non-Current Assets | |||||
| PPE Net | 654 | 683 | 679 | 801 | 1,336 |
| Other Non-Current Assets | 641 | 641 | 645 | 656 | 867 |
| TOTAL | $1,295 | $1,324 | $1,324 | $1,457 | $2,203 |
| Total Assets | $49,109 | $55,348 | $63,325 | $71,754 | $29,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,953 | 447 | 578 | 422 | 891 |
| Accrued Expenses | 7,803 | 7,773 | 5,752 | 6,357 | 11,573 |
| TOTAL | $11,700 | $10,788 | $7,354 | $7,791 | $13,362 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,944 | 2,568 | 1,024 | 1,012 | 898 |
| Other Non-Current Liabilities | 267 | 6,114 | 11,714 | 11,796 | 10,003 |
| TOTAL | $932 | $6,844 | $14,239 | $14,580 | $12,485 |
| Total Liabilities | $12,632 | $17,632 | $21,593 | $22,371 | $25,847 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 685 | 672 | 672 | 671 | 558 |
| Common Shares | 103 | 101 | 101 | 100 | 84 |
| Retained earnings | -362,211 | -356,118 | -350,542 | -340,831 | -331,927 |
| TOTAL | $36,477 | $37,716 | $41,732 | $49,383 | $3,631 |
| Total Liabilities And Equity | $49,109 | $55,348 | $63,325 | $71,754 | $29,478 |